|
⚲
|
| Keyboard |
| Trv GP VI LLC | |
|---|---|
| Firm | Third Rock Ventures LLC |
| Address | 29 Newbury Street, 3rd Floor Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Third Rock Ventures LLC | |||||
| Third Rock Ventures VI LP | 021-448880 | Executive Officer | 1,105.3 M of 1,105.3 M |
786.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Septerna Inc SEPN
Common Stock
|
2025-02-24 | Buy | 18,861 | $6.00 | 113,166 |
|
Septerna Inc SEPN
Common Stock
|
2025-02-21 | Buy | 427,668 | $5.94 | 2,540,348 |
|
Septerna Inc SEPN
Common Stock
|
2025-02-20 | Buy | 612,674 | $5.92 | 3,627,030 |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Conversion | 2,872,956 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Buy | 279,500 | $18.00 | 5,031,000 |
|
Septerna Inc SEPN
Series A Preferred Stock · derivative
|
2024-10-28 | Conversion | 41,250,000 | $0.00 | |
|
Septerna Inc SEPN
Series B Preferred Stock · derivative
|
2024-10-28 | Conversion | 24,737,017 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Conversion | 4,790,773 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Buy | 370,500 | $18.00 | 6,669,000 |
|
Rapport Therapeutics Inc RAPP
Series A Preferred Stock · derivative
|
2024-06-10 | Conversion | 56,091,177 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2024-06-10 | Conversion | 6,551,449 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2024-06-10 | Conversion | 969,218 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series B Preferred Stock · derivative
|
2024-06-10 | Conversion | 298,103 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series A Preferred Stock · derivative
|
2024-06-10 | Conversion | 8,000,000 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Common Stock
|
2023-11-14 | Conversion | 473,786 | ||
|
CARGO Therapeutics Inc CRGX
Series A-1 Preferred Stock · derivative
|
2023-11-14 | Conversion | 23,571,429 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Series A-1 Preferred Stock · derivative
|
2023-11-14 | Conversion | 6,428,571 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Common Stock
|
2023-11-14 | Conversion | 1,737,216 | ||
|
CARGO Therapeutics Inc CRGX
Common Stock
|
2023-11-14 | Buy | 1,333,333 | $15.00 | 19,999,995 |